Investor mix
16 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 63% |
| Private equity | 3 | 19% |
| Angel & family office | 1 | 6% |
| Other / undisclosed | 2 | 13% |
Developer of DNA-based gene therapies for cancer and other genetic diseases
16 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 63% |
| Private equity | 3 | 19% |
| Angel & family office | 1 | 6% |
| Other / undisclosed | 2 | 13% |